<?xml version="1.0" encoding="UTF-8"?>
<ref id="B111">
 <label>111.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yenkoidiok-Douti</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>AE</given-names>
   </name>
   <name>
    <surname>Canepa</surname>
    <given-names>GE</given-names>
   </name>
   <name>
    <surname>Molina-Cruz</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Barillas-Mury</surname>
    <given-names>C</given-names>
   </name>
  </person-group>. 
  <article-title>Engineering a virus-like particle as an antigenic platform for a Pfs47-targeted malaria transmission-blocking vaccine</article-title>. 
  <source>Sci Rep.</source> (
  <year>2019</year>) 
  <volume>9</volume>:
  <fpage>16833</fpage>. 
  <pub-id pub-id-type="doi">10.1038/s41598-019-53208-z</pub-id>
  <?supplied-pmid 31727945?>
  <pub-id pub-id-type="pmid">31727945</pub-id>
 </mixed-citation>
</ref>
